Hudson Bay Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Hudson Bay Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$2.52M	–	1189
2022 Q4	$2.52M	Hold	250,000	–	–	0.03%	560
2022 Q3	$2.48M	Hold	250,000	–	–	0.02%	676
2022 Q2	$2.45M	Hold	250,000	–	–	0.02%	736
2022 Q1	$2.44M	Hold	250,000	–	–	0.03%	654
2021 Q4	$2.43M	Hold	250,000	–	–	0.02%	632
2021 Q3	$2.44M	Hold	250,000	–	–	0.03%	586
2021 Q2	$2.41M	Buy	+250,000	New	+$2.44M	0.03%	579

Hudson Bay Capital Management's MSAC Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 250,000 shares — an estimated $2.52M sold.

Hudson Bay Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $2.52M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Hudson Bay Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 250,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $2.52M.
Hudson Bay Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Hudson Bay Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.52M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.